Myopia, or nearsightedness, is a progressive eye condition that results in blurry distance vision due to elongation of the eye. Myopia is increasing in prevalence and has recently been termed as the “myopic epidemic.” It is estimated that by the year 2050, nearly 50% of the world’s population will be nearsighted.
Age of patient upon initial diagnosis
Ethnicity (greatest prevalence in Asian decent)
Parents with myopia
Less time spent outdoors
More time spent on near tasks (reading & digital devices)
Myopia is the 6th leading cause of blindness worldwide. As it increases, the risk of developing vision threatening complications such as retinal detachments, macular disease, early cataracts, and glaucoma also increases.
Single vision glasses and contact lenses can be prescribed to correct blurred vision associated with nearsightedness, however they do not slow the progression of myopia.
Management options to slow the progression of nearsightedness include:
Soft multifocal contact lenses
Low-dose atropine pharmaceutical drops
Research has indicated that these treatment options can slow myopia by up to 50%.
All children are screened for myopia during their comprehensive eye examinations and evaluated for progression. Contact Mid America Vision Center if you have any additional questions or would like to schedule an appointment!